{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:42:18Z","timestamp":1760550138616},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The interferon-gamma release assay (IGRA) is useful for diagnosing latent tuberculosis infection (LTBI), however the rate of negative conversion is high, especially in dialysis patients. Few studies have focused on predicting persistently positive patients who are at high risk of tuberculosis reactivation. We screened dialysis patients, and used QuantiFERON-TB Gold In-tube (QFT-GIT) to identify LTBI. Of the 157 participants who had initially positive QFT-GIT, 82 had persistently positivity and 75 had negative conversion. The persistently positive group were younger, more were current smokers, and had higher plasma level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and QFT-GIT responses than the negative conversion group. Multivariate logistic regression for persistent positivity revealed that high plasma sTREM-1 and QFT-GIT response, young age and TB contact history were independent factors. Currently smoking had borderline significance. The area under the receiver operating characteristic curve using the multi-factor model was 0.878, higher than 0.821 by QFT-GIT response of 0.95\u2009IU\/ml. In conclusion, dialysis patients with persistent LTBI status may be associated with a young age, high plasma sTREM-1, strong QFT-GIT response, currently smoking, and TB contact history. If resources are limited, these five predictors can be used to prioritize QFT-GIT-positive dialysis patients for LTBI treatment.<\/jats:p>","DOI":"10.1038\/srep34577","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T09:14:54Z","timestamp":1475658894000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population"],"prefix":"10.1038","volume":"6","author":[{"given":"Chin-Chung","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Lin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Jung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,5]]},"reference":[{"key":"BFsrep34577_CR1","unstructured":"Laura Anderson et al. Global Tuberculosis Report 2015 20th edition (World Health Organization, 2015)."},{"key":"BFsrep34577_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archinte.160.10.1513","volume":"160","author":"DN Rose","year":"2000","unstructured":"Rose, D. N. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med 160, 1513\u20131521 (2000).","journal-title":"Arch Intern Med"},{"key":"BFsrep34577_CR3","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1056\/NEJMsa031667","volume":"350","author":"CR Horsburgh Jr.","year":"2004","unstructured":"Horsburgh, C. R. Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350, 2060\u20132067 (2004).","journal-title":"N Engl J Med"},{"key":"BFsrep34577_CR4","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1469-0691.2011.03473.x","volume":"17","author":"SY Li","year":"2011","unstructured":"Li, S. Y. et al. Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study. Clin Microbiol Infect 17, 1646\u20131652 (2011).","journal-title":"Clin Microbiol Infect"},{"key":"BFsrep34577_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/art.23705","volume":"59","author":"DY Chen","year":"2008","unstructured":"Chen, D. Y., Shen, G. H., Hsieh, T. Y., Hsieh, C. W. & Lan, J. L. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum 59, 800\u2013806 (2008).","journal-title":"Arthritis Rheum"},{"key":"BFsrep34577_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0002-9343(79)90240-7","volume":"67","author":"AP Lundin","year":"1979","unstructured":"Lundin, A. P., Adler, A. J., Berlyne, G. M. & Friedman, E. A. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 67, 597\u2013602 (1979).","journal-title":"Am J Med"},{"key":"BFsrep34577_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1378\/chest.113.1.25","volume":"113","author":"M Smirnoff","year":"1998","unstructured":"Smirnoff, M., Patt, C., Seckler, B. & Adler, J. J. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 113, 25\u201327 (1998).","journal-title":"Chest"},{"key":"BFsrep34577_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5414\/CNP67217","volume":"67","author":"RK Venkata","year":"2007","unstructured":"Venkata, R. K., Kumar, S., Krishna, R. P., Kumar, S. B. & Padmanabhan, S. Tuberculosis in chronic kidney disease. Clin Nephrol 67, 217\u2013220 (2007).","journal-title":"Clin Nephrol"},{"key":"BFsrep34577_CR9","first-page":"92","volume":"8","author":"HC Fang","year":"2004","unstructured":"Fang, H. C. et al. Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis 8, 92\u201397 (2004).","journal-title":"Int J Tuberc Lung Dis"},{"key":"BFsrep34577_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jinf.2013.07.029","volume":"67","author":"CC Shu","year":"2013","unstructured":"Shu, C. C. et al. Dynamic changes in positive interferon-gamma release assay in a dialysis population: An observational cohort study. J Infect 67, 529\u2013535 (2013).","journal-title":"J Infect"},{"key":"BFsrep34577_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7883\/yoken.63.99","volume":"63","author":"H Simsek","year":"2010","unstructured":"Simsek, H. et al. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J Infect Dis 63, 99\u2013102 (2010).","journal-title":"Jpn J Infect Dis"},{"key":"BFsrep34577_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1164\/rccm.200402-232OC","volume":"170","author":"I Brock","year":"2004","unstructured":"Brock, I., Weldingh, K., Lillebaek, T., Follmann, F. & Andersen, P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170, 65\u201369 (2004).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR13","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","volume":"177","author":"R Diel","year":"2008","unstructured":"Diel, R., Loddenkemper, R., Meywald-Walter, K., Niemann, S. & Nienhaus, A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177, 1164\u20131170 (2008).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR14","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek, G. H. et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 59, 1\u201325 (2010).","journal-title":"MMWR Recomm Rep"},{"key":"BFsrep34577_CR15","first-page":"496","volume":"98","author":"MC Yu","year":"1999","unstructured":"Yu, M. C. et al. Annual risk of tuberculous infection in Taiwan, 1996\u20131998. J Formos Med Assoc 98, 496\u2013499 (1999).","journal-title":"J Formos Med Assoc"},{"key":"BFsrep34577_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1440-1843.1998.tb00132.x","volume":"3","author":"KJ Bai","year":"1998","unstructured":"Bai, K. J. et al. Tuberculous empyema. Respirology 3, 261\u2013266 (1998).","journal-title":"Respirology"},{"key":"BFsrep34577_CR17","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/ndt\/gfn748","volume":"24","author":"PA Triverio","year":"2009","unstructured":"Triverio, P. A. et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 24, 1952\u20131956 (2009).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep34577_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","volume":"37","author":"SS Lee","year":"2009","unstructured":"Lee, S. S. et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 37, 96\u2013102 (2009).","journal-title":"Infection"},{"key":"BFsrep34577_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2215\/CJN.01790210","volume":"5","author":"SS Lee","year":"2010","unstructured":"Lee, S. S. et al. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 5, 1451\u20131457 (2010).","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFsrep34577_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jinf.2011.11.028","volume":"64","author":"JY Wang","year":"2012","unstructured":"Wang, J. Y. et al. Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis. J Infect 64, 291\u2013298 (2012).","journal-title":"J Infect"},{"key":"BFsrep34577_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1471-2334-10-220","volume":"10","author":"FC Ringshausen","year":"2010","unstructured":"Ringshausen, F. C. et al. Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis 10, 220 (2010).","journal-title":"BMC Infect Dis"},{"key":"BFsrep34577_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","volume":"187","author":"IM Adetifa","year":"2013","unstructured":"Adetifa, I. M. et al. Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am J Respir Crit Care Med 187, 439\u2013445 (2013).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","volume":"187","author":"JZ Metcalfe","year":"2013","unstructured":"Metcalfe, J. Z. et al. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 187, 206\u2013211 (2013).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jinf.2012.10.017","volume":"66","author":"F Bartalesi","year":"2013","unstructured":"Bartalesi, F. et al. Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment. J Infect 66, 346\u2013356 (2013).","journal-title":"J Infect"},{"key":"BFsrep34577_CR25","doi-asserted-by":"publisher","first-page":"e3813","DOI":"10.1097\/MD.0000000000003813","volume":"95","author":"CC Shu","year":"2016","unstructured":"Shu, C. C. et al. Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay. Medicine (Baltimore) 95, e3813 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"BFsrep34577_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. & Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60, 646\u2013649 (1973).","journal-title":"Br J Surg"},{"key":"BFsrep34577_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","volume":"163","author":"A Lalvani","year":"2001","unstructured":"Lalvani, A. et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163, 824\u2013828 (2001).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2334-10-57","volume":"10","author":"AM Dyrhol-Riise","year":"2010","unstructured":"Dyrhol-Riise, A. M. et al. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 10, 57 (2010).","journal-title":"BMC Infect Dis"},{"key":"BFsrep34577_CR29","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.5588\/ijtld.11.0017","volume":"15","author":"DB Banach","year":"2011","unstructured":"Banach, D. B. & Harris, T. G. Indeterminate QuantiFERON(R)-TB Gold results in a public health clinic setting. Int J Tuberc Lung Dis 15, 1623\u20131630 (2011).","journal-title":"Int J Tuberc Lung Dis"},{"key":"BFsrep34577_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1164\/rccm.200904-0549OC","volume":"180","author":"HH Lin","year":"2009","unstructured":"Lin, H. H., Ezzati, M., Chang, H. Y. & Murray, M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 180, 475\u2013480 (2009).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR31","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1164\/ajrccm.162.5.2003028","volume":"162","author":"RM Jasmer","year":"2000","unstructured":"Jasmer, R. M. et al. Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis. Am J Respir Crit Care Med 162, 1648\u20131652 (2000).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep34577_CR32","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.5588\/ijtld.10.0786","volume":"15","author":"CC Shu","year":"2011","unstructured":"Shu, C. C. et al. Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease. Int J Tuberc Lung Dis 15, 1415\u20131420 (2011).","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:12:22Z","timestamp":1672884742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep34577"],"URL":"https:\/\/doi.org\/10.1038\/srep34577","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,5]]},"assertion":[{"value":"16 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34577"}}